Meletios Dimopoulos, MD
Improved understanding of Waldenström’s macroglobulinemia (WM) and expanded treatment options have made individualized treatment based on clinical indications a feasible strategy, Meletios Dimopoulos, MD, said at the 2016 Society of Hematologic Oncology annual… Continue reading
Michael Knowlton has found a new way of embracing life while living with WM. This video is about his journey and story of inspiration.
If you have Waldenstrom’s Macroglobulinemia (WM) or you are a caregiver of a patient with WM, you can help by completing the surveys.
Lymphoma Canada, in partnership with the Canadian Organization… Continue reading
This great guide is helpful in helping make healthy choices for you and your home.
According to Steven P. Treon, MD, PhD, mutations in MYD88 and CXCR4 can effectively be used to tailor treatment for patients with Waldenström’s macroglobulinemia (WM).
“Linking biological data to clinical data is beginning to identify clinically distinct… Continue reading
Article from the New England Journal of Medicine
Waldenstrom’s Macroglobulinemia is in part named for the Swedish scientist, Jan Gosta Waldenstrom, who identified the disease in the 1940s. The term macroglobulinemia comes from the characteristics of the protein molecule where the cancer… Continue reading